UGI Corporation
NYSEUGI Corporation reports Q2 2026 results today, arriving on the back of a fresh analyst downgrade, a persistent short build, and a stock already nursing a 6.7% weekly loss. The most important pre-earnings development is not in the data — it is in analyst conviction. Jefferies downgraded UGI to Hold from Buy last week, cutting its price target to $40 from $45. That move is significant…
Snapshot as of 22 Jun 2026
UGI Corporation reports Q2 2026 results today, arriving on the back of a fresh analyst downgrade, a persistent short build, and a stock already nursing a 6.7% weekly loss. The most important pre-earnings development is…
UGI heads into the post-earnings session carrying fresh damage: Q2 adjusted EPS of $2.09 missed the $2.38 consensus by nearly 12%, revenue of $2.69B fell well short of the $3.08B estimate, and management cut full-year…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for UGI — free to start on ORTEX.
Sign up for free →Open UGI on ORTEX